header-logo header-logo

25 November 2016
Issue: 7724 / Categories: Case law , Law digest , In Court
printer mail-detail

NHS

R (on the application of National Aids Trust) v National Health Service Commissioning Board (NHS England) and another [2016] EWCA Civ 1100, [2016] All ER (D) 73 (Nov)

The Court of Appeal dismissed NHS England’s appeal from a decision of the Administrative Court, allowing the National Aids Trust’s application for judicial review of NHS England’s decision to refuse to consider, in its commissioning process, an anti-retroviral drug to be used on a preventative basis for those at high risk of contracting AIDS (PrEP). NHS England had misdirected itself in law when it had concluded that it had had no power to commission PrEP.

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Hugh James—Jonathan Askin

Hugh James—Jonathan Askin

London corporate and commercial team announces partner appointment

Michelman Robinson—Daniel Burbeary

Michelman Robinson—Daniel Burbeary

Firm names partner as London office managing partner

Kingsley Napley—Jonathan Grimes

Kingsley Napley—Jonathan Grimes

Firm appoints new head of criminal litigation team

NEWS
Hugh James has secured 500 places on King’s College London’s new AI Literacy for Law course as part of a major firm-wide push to strengthen its responsible use of generative artificial intelligence
The criminal courts will sit to their maximum capacity next year, after the Lord Chancellor David Lammy lifted the cap on Crown Court sitting days
The Lord Chancellor David Lammy has set out his plans for ‘Blitz courts’, a national listing framework and other elements of the Leveson reforms
A former Commerzbank analyst has been sentenced to eight months in prison for lying during an employment tribunal hearing
The Information Commissioner’s Office (ICO) has joined with 60 data protection authorities from around the world to call for ‘urgent regulatory attention’ to the dangers of artificial intelligence (AI)
back-to-top-scroll